참고문헌 (66)

1. Drugs Bardsley-Elliot 58 851 1999 10.2165/00003495-199958050-00007 Oseltamivir 

   상세보기

2. Ann Pharmacother McNicholl 35 57 2001 10.1345/aph.10118 Neuraminidase inhibitors: Zanamivir and oseltamivir 

   상세보기

3. Drugs Shigeta 58 861 1999 10.2165/00003495-199958050-00009 Oseltamivir (Guest Commentaries) 

   상세보기

4. Antiviral Res Leneva 48 101 2000 10.1016/S0166-3542(00)00123-6 The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses 

   상세보기

5. PLoS One Hanshaoworakul 4 e6051 2009 10.1371/journal.pone.0006051 Severe human influenza infections in Thailand: Oseltamivir treatment and risk factors for fatal outcome 

   상세보기

6. Drugs Fleming 58 861 1999 10.2165/00003495-199958050-00008 Oseltamivir (Guest Commentaries) 

   상세보기

7. Lancet Nicholson 355 1845 2000 10.1016/S0140-6736(00)02288-1 Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial 

   상세보기

8. Antimircob Agents Chemother Mendel 42 640 1998 10.1128/AAC.42.3.640 Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection 

   상세보기

9. Expert Opin Drug Saf Schirmer 8 357 2009 10.1517/14740330902840519 Oseltamivir for treatment and prophylaxis of influenza infection 

   상세보기

10. Drug Metab Dispos Hill 30 13 2002 10.1124/dmd.30.1.13 The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies 

    상세보기

11. Expert Opin Pharmacother Doucette 2 1671 2001 10.1517/14656566.2.10.1671 Oseltamivir: A clinical and pharmacological perspective 

    상세보기

12. Clin Pharmacokinet He 37 471 1999 10.2165/00003088-199937060-00003 Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802 

    상세보기

13. Br J Clin Pharmacol Snell 59 598 2005 10.1111/j.1365-2125.2005.02340.x Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate 

    상세보기

14. J Clin Pharmacol Massarella 40 836 2000 10.1177/00912700022009567 The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers 

    상세보기

15. Eur J Clin Pharmacol Oo 59 411 2003 10.1007/s00228-003-0639-6 Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years 

    상세보기

16. Paediatr Drugs Oo 3 229 2001 10.2165/00128072-200103030-00005 Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children 

    상세보기

17. JAMA Treanor 283 1016 2000 10.1001/jama.283.8.1016 Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial 

    상세보기

18. BMJ Clin Evidence Jefferson 3 911 2009 Influenza 

19. J Antimicrob Chemother Aoki 51 123 2003 10.1093/jac/dkg007 Early administration of oral oseltamivir increases the benefits of influenza treatment 

    상세보기

20. Lancet Infect Dis Burch 9 537 2009 10.1016/S1473-3099(09)70199-9 Prescription of anti-influenza drugs for healthy adults: A systematic review and meta-analysis 

    상세보기

21. Arch Intern Med Kaiser 163 1667 2003 10.1001/archinte.163.14.1667 Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations 

    상세보기

22. Curr Med Res Opin Lin 22 75 2006 10.1185/030079906X80297 A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population 

    상세보기

23. Ann Intern Med Rothberg 139 321 2003 10.7326/0003-4819-139-5_Part_1-200309020-00007 Management of influenza in adults older than 65 years of age: Cost-effectiveness of rapid testing and antiviral therapy 

    상세보기

24. JAMA Hayden 282 1240 1999 10.1001/jama.282.13.1240 Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment 

    상세보기

25. N Engl J Med Hayden 341 1336 1999 10.1056/NEJM199910283411802 Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza 

    상세보기

26. BMJ Cooper 326 1235 2003 10.1136/bmj.326.7401.1235 Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-analyses of randomised controlled trials 

    상세보기

27. JAMA Welliver 285 748 2001 10.1001/jama.285.6.748 Effectiveness of oseltamivir in preventing influenza in household contacts: A randomized controlled trial 

    상세보기

28. J Infect Dis Hayden 189 440 2004 10.1086/381128 Management of influenza in households: A prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis 

    상세보기

29. J Am Geriatr Soc Risebrough 53 444 2005 10.1111/j.1532-5415.2005.53162.x Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities 

    상세보기

30. J Am Geriatr Soc Peters 49 1025 2001 10.1046/j.1532-5415.2001.49204.x Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population 

    상세보기

31. Intern Med Shijubo 41 366 2002 10.2169/internalmedicine.41.366 Experience with oseltamivir in the control of nursing home influenza A outbreak 

    상세보기

32. Bone Marrow Transplant Machado 34 111 2004 10.1038/sj.bmt.1704534 Use of Oseltamivir to control influenza complications after bone marrow transplantation 

    상세보기

33. Pediatr Infect Dis J Whitley 20 127 2001 10.1097/00006454-200102000-00002 Oral oseltamivir treatment of influenza in children 

    상세보기

34. Pediatr Infect Dis J Johnston 24 225 2005 10.1097/01.inf.0000154322.38267.ce Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma 

    상세보기

35. Pediatrics Piedra 124 170 2009 10.1542/peds.2008-0977 Effects of oseltamivir on influenza-related complications in children with chronic medical conditions 

    상세보기

36. Euro Surveill Wallensten 14 19285 2009 10.2807/ese.14.30.19285-en Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England 

    상세보기

37. Clin Infect Dis Sugaya 44 197 2007 10.1086/509925 Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children 

    상세보기

38. Pediatr Infect Dis J Huang 28 647 2009 10.1097/INF.0b013e3181986bf9 Influenza-associated central nervous system dysfunction in Taiwanese children: Clinical characteristics and outcomes with and without administration of oseltamivir 

    상세보기

39. Int J Clin Pract Smith 63 596 2009 10.1111/j.1742-1241.2009.02010.x Sacks S. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment 

    상세보기

40. Euro Surveill Kitching 14 19287 2009 10.2807/ese.14.30.19287-en Oseltamivir adherence and side effects among children in three London schools affected by influenza A (H1N1)v, May 2009: An internet-based cross-sectional survey 

    상세보기

41. CMAJ Tanaka 181 55 2009 10.1503/cmaj.090866 Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women 

    상세보기

42. BMJ Stohr 326 1223 2003 10.1136/bmj.326.7401.1223 Preventing and treating influenza: Neuraminidase inhibitors are clinically effective but have limitations 

    상세보기

43. Immunopharmacology Burger 47 45 2000 10.1016/S0162-3109(99)00184-8 Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice 

    상세보기

44. N Engl J Med Moscona 353 2633 2005 10.1056/NEJMp058291 Oseltamivir resistance-disabling our influenza defenses 

    상세보기

45. N Engl J Med de Jong 353 2667 2005 10.1056/NEJMoa054512 Oseltamivir resistance during treatment of influenza A (H5N1) infection 

    상세보기

46. PLoS Med White 6 e1000091 2009 10.1371/journal.pmed.1000091 What is the optimal therapy for patients with H5N1 influenza? 

    상세보기

47. J Antimicrob Chemother Ward 55 i5 2005 10.1093/jac/dki018 Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic 

    상세보기

48. Proc Natl Acad Sci USA Tumpey 99 13849 2002 10.1073/pnas.212519699 Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus 

    상세보기

49. Nature Le 437 1108 2005 10.1038/4371108a Avian flu: Isolation of drug-resistant H5N1 virus 

    상세보기

50. Antivir Ther Aoki 12 603 2007 10.1177/135965350701200S04.1 Influenza virus susceptibility and resistance to oseltamivir 

    상세보기

51. JAMA Gooskens 301 1042 2009 10.1001/jama.2009.297 Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A (H1N1) virus 

    상세보기

52. Antimicrob Agents Chemother McKimm-Breschkin 47 2264 2003 10.1128/AAC.47.7.2264-2272.2003 Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir 

    상세보기

53. Science Enserink 323 1162 2009 10.1126/science.323.5918.1162 Newsfocus: A ′wimpy′ flu strain mysteriously turns scary 

    상세보기

54. PLoS One Soderstrom 4 e6064 2009 10.1371/journal.pone.0006064 Detection of the antiviral drug oseltamivir in aquatic environments 

    상세보기

55. PLoS Med Shay 6 e1000103 2009 10.1371/journal.pmed.1000103 Can we ′′hedge′′ against the development of antiviral resistance among pandemic influenza viruses? 

    상세보기

56. Clin Infect Dis Poland 48 1254 2009 10.1086/598989 Influenza virus resistance to antiviral agents: A plea for rational use 

    상세보기

57. Clin Infect Dis Stephenson 48 389 2009 10.1086/596311 Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children 

    상세보기

58. Eur Surveill Hall 14 19282 2009 10.2807/ese.14.30.19282-en Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir 

    상세보기

59. Emerg Infect Dis Besselaar 14 1809 2008 10.3201/eid1411.080958 Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa 

    상세보기

60. Emerg Infect Dis Cheng 15 966 2009 10.3201/eid1506.081357 Oseltamivir and amantadine-resistant influenza viruses A (H1N1) 

    상세보기

61. JAMA Dharan 301 1034 2009 10.1001/jama.2009.294 Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States 

    상세보기

62. Emerg Infect Dis Hauge 15 155 2009 10.3201/eid1502.081031 Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08 

    상세보기

63. Jpn J Infect Dis Kawakami 62 83 2009 10.7883/yoken.JJID.2009.83 Isolation of Oseltamivir-resistant influenza A/ H1N1 virus of different origins in Yokohama city, Japan, during the 2007-2008 influenza season 

    상세보기

64. Emerg Infect Dis Meijer 15 552 2009 10.3201/eid1504.181280 Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season 

    상세보기

65. N Engl J Med Moscona 360 953 2009 10.1056/NEJMp0900648 Global transmission of oseltamivir-resistant influenza 

    상세보기

66. JAMA Weinstock 301 1066 2009 10.1001/jama.2009.324 The evolution of influenza resistance and treatment 

    상세보기